Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Measles + rubella) vaccine by Vaxxas for Measles: Likelihood of Approval
(Measles + rubella) vaccine is under clinical development by Vaxxas and currently in Phase I for Measles. According to GlobalData,...
(Measles + rubella) vaccine by Vaxxas for Rubella (German Measles): Likelihood of Approval
(Measles + rubella) vaccine is under clinical development by Vaxxas and currently in Phase I for Rubella (German Measles). According...
(Measles + rubella) vaccine by Indian Immunologicals for Rubella (German Measles): Likelihood of Approval
(Measles + rubella) vaccine is under clinical development by Indian Immunologicals and currently in Phase III for Rubella (German Measles)....